TW200743492A - Hyaluronic acid used for purpose of anti-oxidation and proliferation on cartilage cells - Google Patents
Hyaluronic acid used for purpose of anti-oxidation and proliferation on cartilage cellsInfo
- Publication number
- TW200743492A TW200743492A TW095119069A TW95119069A TW200743492A TW 200743492 A TW200743492 A TW 200743492A TW 095119069 A TW095119069 A TW 095119069A TW 95119069 A TW95119069 A TW 95119069A TW 200743492 A TW200743492 A TW 200743492A
- Authority
- TW
- Taiwan
- Prior art keywords
- cartilage cells
- hyaluronic acid
- proliferation
- oxidation
- acid used
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
This invention is related to the purpose of using hyaluronic acid (also named uronic acid) to improve the oxidation damage to cartilage cells and further promote the proliferation of cartilage cells. More especially, this invention is related to the purpose of using hyaluronic acid with its molecule weight ranging between 600 to 1200 thousand Dalton to protect cartilage cells from damage of reactive oxygen and promote the proliferation of cartilage cells. This invention is also related to the purpose of using hyaluronic acid to manufacture medicines for treating or preventing arthritis and oral food or drinks for improving arthritis symptoms.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW095119069A TW200743492A (en) | 2006-05-29 | 2006-05-29 | Hyaluronic acid used for purpose of anti-oxidation and proliferation on cartilage cells |
JP2007128251A JP2007314531A (en) | 2006-05-29 | 2007-05-14 | Hyaluronic acid used in application of anti-oxidation and hyperplasia of chondrocyte |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW095119069A TW200743492A (en) | 2006-05-29 | 2006-05-29 | Hyaluronic acid used for purpose of anti-oxidation and proliferation on cartilage cells |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200743492A true TW200743492A (en) | 2007-12-01 |
Family
ID=38848727
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW095119069A TW200743492A (en) | 2006-05-29 | 2006-05-29 | Hyaluronic acid used for purpose of anti-oxidation and proliferation on cartilage cells |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP2007314531A (en) |
TW (1) | TW200743492A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8462765B2 (en) * | 2008-08-20 | 2013-06-11 | Qualcomm Incorporated | Method and apparatus to perform ranging operations for wireless stations |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6391864B1 (en) * | 1998-08-19 | 2002-05-21 | Joint Juice, Inc. | Food supplement containing a cartilage supplement |
MXPA01011542A (en) * | 2001-11-13 | 2003-05-22 | Alcon Inc | Regeneration of articular cartilage damaged by osteoarthritis i and ii, by means of intra-articular application of sodium hyaluronate and chondroitin sulphate in a gel carrier. |
-
2006
- 2006-05-29 TW TW095119069A patent/TW200743492A/en unknown
-
2007
- 2007-05-14 JP JP2007128251A patent/JP2007314531A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2007314531A (en) | 2007-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE488242T1 (en) | ANTI-INFLAMMATORY AND/OR ANALGESIC COMPOSITION FOR THE INTESTINAL CONTAINING BRANCHED MALTODEXTRINS | |
MX2009005455A (en) | (r)-n-stereoisomers of 7,8-saturated-4,5-epoxy-morphinanium analogs. | |
MY159360A (en) | Barley and uses thereof | |
MY155418A (en) | Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives | |
NZ620326A (en) | Cd37 immunotherapeutic combination therapies and uses thereof | |
WO2011060304A3 (en) | Oxygen scavengers, compositions comprising the scavengers, and artcles made from the compositions | |
WO2010144344A3 (en) | Melanocortin receptor-specific peptides | |
IN2012DN01233A (en) | ||
MX2010006033A (en) | 4-(4-cyano-2-thioaryl)dihydropyrimidinones and use thereof. | |
IL188475A0 (en) | Pyrido [2,3-d]pyrimidine-2,4-diamine compounds as ptpib inhibitors | |
TN2010000086A1 (en) | Antiviral composition comprising a sulfated polysaccharide | |
IL172773A (en) | Formulations for the treatment of arthritis conditions | |
UA91848C2 (en) | Diosmetin derivatives for the treatment and prevention of thrombotic pathologies | |
GB0714228D0 (en) | Oral compositions. Their preparation and use | |
MY158106A (en) | Inhibitors of e1 activating enzymes | |
MX346003B (en) | Antibacterial oral composition. | |
AU2010230585A8 (en) | Autotaxin inhibitors | |
MY138708A (en) | Biaryloxymethylarenecarboxylic acids | |
MY149606A (en) | Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment | |
IN2012DN05020A (en) | ||
TW200602042A (en) | Heterocyclic derivatives for treatment of hyperlipidemia and related diseases | |
UA102238C2 (en) | 4-(4-cyano-2-thioaryl)dihydro-pyrimidinones and use thereof | |
TW200801032A (en) | Azaheterocyclyl derivatives of androstanes and androstenes as medicaments for cardiovascular disorders | |
GB2476418A (en) | A medicinal product and treatment | |
TW200743492A (en) | Hyaluronic acid used for purpose of anti-oxidation and proliferation on cartilage cells |